BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06428019-completion@plaintrial.com
DTSTAMP:20261027T011431Z
DTSTART;VALUE=DATE:202803
SUMMARY:A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult
  Participants Receiving Oral Venetoclax in Combination With Intravenously 
 Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chroni
 c Lymphocytic Leukemia (CLL) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06428019
URL:https://plaintrial.com/trial/NCT06428019
END:VEVENT
END:VCALENDAR